SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-031270
Filing Date
2023-03-10
Accepted
2023-03-10 17:07:29
Documents
12
Period of Report
2023-03-10
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm239217d1_8k.htm   iXBRL 8-K 23651
  Complete submission text file 0001104659-23-031270.txt   198552

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ckpt-20230310.xsd EX-101.SCH 3045
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ckpt-20230310_lab.xml EX-101.LAB 34476
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ckpt-20230310_pre.xml EX-101.PRE 22603
6 EXTRACTED XBRL INSTANCE DOCUMENT tm239217d1_8k_htm.xml XML 3720
Mailing Address 95 SAWYER ROAD SUITE 110 WALTHAM MA 02453
Business Address 95 SAWYER ROAD SUITE 110 WALTHAM MA 02453 781-652-4500
Checkpoint Therapeutics, Inc. (Filer) CIK: 0001651407 (see all company filings)

IRS No.: 472568632 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38128 | Film No.: 23724625
SIC: 2834 Pharmaceutical Preparations